The Japan Myasthenia Gravis Association (JMGA) will host the 3rd 'Myasthenia Gravis Day' Commemorative Forum in Suita City, Osaka, on May 31, 2026.

Myasthenia Gravis (MG) is a designated intractable disease caused by immune system abnormalities, resulting in muscle weakness and fatigue. In recent years, the treatment landscape has shifted significantly with the arrival of new treatments such as molecular targeted drugs.

At this forum, patients, families, and medical professionals will gather to discuss themes such as 'MG treatment in the era of molecular targeted drugs: working together with patients.'

About 'MG Day' June 2nd is 'MG Day.' Myasthenia Gravis is abbreviated as MG. The association registered this date with the Japan Anniversary Association in 2024 to raise awareness of the disease. Officially, it is called 'Japan Myasthenia Gravis Day.'

Forum Overview 3rd 'Myasthenia Gravis Day' Commemorative Forum

[Date and Time] May 31, 2026 (Sun) 13:30–17:10 (Reception starts at 13:00)

[Venue] Sunnystone Hotel, 'Fuji Room' (10-3 Hiroshiba-cho, Suita City, Osaka)

[Organizer] Japan Myasthenia Gravis Association (JMGA)

[Capacity] 120 people (Pre-registration required)

[Participants] Patients, families, medical professionals, and the general public

Main Program

- Live performance by MG singer-songwriter Ami Featuring a live performance by Ami, a singer-songwriter living with MG.

- Voices of patients Sharing experiences and thoughts of those living with MG.

- Commemorative medical lecture Tomoya Kubota, Associate Professor, Graduate School of Medicine, Osaka University Theme: 'MG treatment in the era of molecular targeted drugs: working together with patients'

- Panel discussion Multi-faceted discussion on patient support and social issues in the new era of treatment.

How to Apply Please apply via the web form below: https://forms.gle/BbQfzG1Dn6ju38vNA

Contact Japan Myasthenia Gravis Association (JMGA) E-mail: [email protected]

FACT BOX

  • Source: PR TIMES
  • Category: Event